Submit a Research Abstract



The ISHLT2019 Abstract Submission Site is now closed.

Abstract submission content should include:
 
  1. Brief statement of purpose of the study (goal or hypothesis being tested)
  2. Statement of methods and procedures used
  3. Summary of results, presented in sufficient detail to support the conclusion
  4. Conclusion

Click any of the Abstract Categories below to view a drop down of available sub-categories.

 
  • Immunology, Inflammation, Immunosuppression
  • Models of Organ Preservation, Perfusion and Graft Injury
  • Xenotransplantation/Regenerative Medicine/Artificial Organs
  • Other
  • Heart
  • Lung
  • MCS
  • Other
  • Patient Care Pathways
  • Quality of Life
  • Therapeutics and Pharmacology
  • Other
  • Acute Rejection
  • Clinical Ex-Vivo Heart Perfusion and Preservation
  • Coronary Artery Vasculopathy
  • Diagnostics/Patient Management
  • Donor Management and Organ Allocation
  • Immunosuppression, Therapeutics and Pharmacology
  • Infectious Diseases
  • Primary Graft Dysfunction
  • Quality of Life
  • Other
  • Heart
  • Lung
  • MCS
  • Pediatrics
  • Acute Rejection
  • Candidate Selection for Advanced Therapies
  • Chronic Lung Allograft Dysfunction
  • Clinical Ex-Vivo Lung Perfusion and Preservation
  • Diagnostics/Patient Management
  • Donor Management and Organ Allocation
  • Immunosuppression, Therapeutics and Pharmacology
  • Infectious Diseases
  • Lung Failure
  • Primary Graft Dysfunction
  • Quality of Life
  • Other
  • Complications Bleeding/Thrombosis
  • Complications Infection
  • Complications Other
  • Devices and Engineering
  • ECMO/Short-Term Support
  • Patient Selection
  • Physiology and Patient Management
  • Quality of Life
  • Surgical Techniques
  • Therapeutics and Pharmacology
  • Other
  • Allied Health
  • Nursing
  • Quality of Life
  • Social Science
  • Symptom Management/Self-Care
  • Heart
  • Lung
  • Heart Failure
  • Heart Transplantation
  • Lung
  • MCS
  • Heart
  • Lung
  • MCS
  • Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
  • Quality of Life
  • Pulmonary Arterial Hypertension
  • Pulmonary Hypertension due to Heart or Lung Disease
  • Physiology/RV Failure/Complications
  • Therapeutics and Pharmacology
  • Other